Prothena Corp Public (PRTA) Revenue Growth (1y) (2013 - 2026)
Prothena Corp Public (PRTA) Revenue Growth (1y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,222.41 Bn | 67,222.13 Bn | - | - |
| 2 | Nanobiotix | 1,909.44 Bn | 1,909.38 Bn | - | - |
| 3 | Akari Therapeutics | 989.71 Bn | 989.71 Bn | - | - |
| 4 | BeOne Medicines | 471.12 Bn | 466.33 Bn | 1.35 Bn | 35.46% |
| 5 | Vertex Pharmaceuticals | 121.84 Bn | 114.59 Bn | 2.59 Bn | 7.82% |
| 6 | Regeneron Pharmaceuticals | 69.89 Bn | 61.14 Bn | 3.31 Bn | 19.04% |
| 7 | Belite Bio | 62.74 Bn | 62.74 Bn | - | - |
| 8 | Argenx Se | 55.83 Bn | 50.64 Bn | 1.41 Bn | 64.03% |
| 9 | Alnylam Pharmaceuticals | 37.34 Bn | 34.34 Bn | 959.66 Mn | 96.43% |
| 10 | Prothena Corp Public | 469.14 Mn | 139.68 Mn | - | 1,706.36% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1,706.36% |
| Dec 31, 2025 | -99.01% |
| Sep 30, 2025 | 148.97% |
| Jun 30, 2025 | -96.65% |
| Mar 31, 2025 | 5,556.00% |
| Dec 31, 2024 | 571.84% |
| Sep 30, 2024 | -98.86% |
| Jun 30, 2024 | 3,184.75% |
| Mar 31, 2024 | -97.69% |
| Dec 31, 2023 | -99.37% |
| Sep 30, 2023 | 5,494.33% |
| Jun 30, 2023 | 206.33% |
| Mar 31, 2023 | 88.12% |
| Dec 31, 2022 | 4,159.64% |
| Sep 30, 2022 | -98.91% |
| Jun 30, 2022 | -97.82% |
| Mar 31, 2022 | 620.63% |
| Dec 31, 2021 | 225.56% |
| Sep 30, 2021 | 88,545.86% |
| Jun 30, 2021 | 30,705.64% |